IWT score for predicting cardiac amyloidosis in patients with hypertensive heart disease

Yuna Matsumoto1, Naoko Ichikawa2,3, Yuina Matsuzawa1

  • 1Clinical Laboratory, St. Luke's International Hospital, Tokyo, Japan.

Insights

Half of patients with Hypertensive Heart Disease (HHD) show increased wall thickness (IWT) scores suggesting cardiac amyloidosis (CA). This study identifies key echocardiographic factors influencing these scores in HHD patients.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Diagnostic Echocardiography

Background:

  • Early detection of cardiac amyloidosis (CA) is vital for improving patient prognosis due to recent therapeutic advancements.
  • Increased wall thickness (IWT) scoring, proposed in 2020, aids echocardiographic evaluation for CA.
  • A significant portion of CA patients are initially diagnosed with other cardiomyopathies, like Hypertensive Heart Disease (HHD).

Purpose of the Study:

  • To investigate characteristic IWT score patterns in patients diagnosed with Hypertensive Heart Disease (HHD).
  • To assess the controversy surrounding the use of IWT scores for all patients with left ventricular wall thickening.
  • To identify factors influencing IWT score classification in HHD patients with suspected CA.

Main Methods:

  • Echocardiographic assessment of patients with HHD between August and November 2024.
  • Calculation of IWT scores using transthoracic echocardiography.
  • Logistic regression analysis of mild left ventricular hypertrophy (LVH) cases with IWT scores between 2 and 7 (gray zone) to identify influencing parameters.

Main Results:

  • Out of 121 HHD patients, 51% fell into the suspected CA gray zone based on IWT scores.
  • Systolic apex-to-base ratio (SAB), relative wall thickness (RWT), and TAPSE significantly influenced IWT scores.
  • Modifications to SAB formula and TAPSE cutoff (17 mm) reduced gray zone cases to 29%.

Conclusions:

  • Approximately half of Hypertensive Heart Disease patients exhibit IWT scores that overlap with those suggestive of cardiac amyloidosis.
  • Key echocardiographic parameters like SAB, RWT, and TAPSE are crucial for differentiating HHD from CA in borderline cases.
  • Refining IWT scoring criteria can improve diagnostic accuracy and reduce misclassification in HHD patients.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
354
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
358
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
190
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
653
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
281